Ranger DCB has a low tip entry profile with 0.014”/0.018” guidewire compatibility
Ranger DCB's low profile and tapered tip enables a smooth delivery with excellent trackability and navigation through alternative access sites.¹
Efficient drug transfer
TransPax™ (citrate ester + low dose paclitaxel) is a next-generation coating that enables highly efficient drug transfer into the lesion.²⁻⁴
Ranger DCB product details
Ranger DCB has a comprehensive matrix.
Proprietary loading tool
Serves as the balloon and drug protector to help prevent drug loss during insertion and limit the physician’s exposure to the drug.
*Kaplan-Meier Estimate. 88.4% Primary Patency in the COMPARE Head-to-Head RCT. 1-Year Results published in the European Heart Journal. doi.org/10.1093/eurheartj/ehaa049. 89.8% Primary Patency in the RANGER II SFA RCT. 1-Year Results published in JACC:CI. doi.org/10.1016/j.jcin.2021.03.021.
**Gongora C, et al. Comparative Drug-Coated Balloon Study, JACC Cardiovasc Interv. 2015;doi.org/10.1016/j.jcin.2015.03.020.
***The limit of quantification was defined as <1 ng/mL. At 1 hour, 11 of 12 patients had no measurable levels of paclitaxel in their bloodstream. At 3 hours, the 12th patient had no measurable levels of paclitaxel. RANGER II SFA PK Substudy. RANGER II SFA RCT 1-Year Results published in JACC:CI. doi.org/10.1016/j.jcin.2021.03.021.
1. Boston Scientific Data on File. Ranger Catheter Competitive Testing Report, 92517674. Measurements from 6 x 120 devices for Ranger DCB, Lutonix™ 035.
2. Sachar R, et al. RANGER II SFA PK Substudy. 2019.
3. Steiner S, et al. COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J. 2020;41:2541–2552.
4. Sachar R, et al. RANGER II SFA Investigators. 1-year results from the RANGER II SFA randomized trial of the Ranger drugcoated balloon. JACC Cardiovasc Interv. 2021;10:1123–1133.
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.